4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-039730
Options or other derivatives
- Director acquired 43,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Stalfort John A III Director | 2023-06-22 | Grant or award · Stock Option (right to buy) | +43,800 | 43,800 | D | ||
Loading xslF345X04/doc4.xml…